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ABSTRACT 
The present research study was conducted to assess the prevalence and pattern of dyslipidemia in 
apparently healthy urban obese adults residing in South Delhi. Dyslipidemia and obesity are two 
prominent contributing risk factors for cardiovascular disease. This cross-sectional study was conducted 
among 150 apparently healthy obese adults with a body mass index of ≥25 kg/m2. Data regarding the 
socio-demographic characteristics as well as anthropometric parameters were collected. To evaluate 
serum lipid levels fasting blood samples were collected by trained technicians and analysis was carried 
out in a certified laboratory. Dyslipidemia was defined as the presence of hypercholesterolemia, high 
levels of Low-Density Lipoprotein (LDL) cholesterol,  and /or lower concentration of High-Density 
Lipoprotein (HDL), present alone or in combination. The overall prevalence of dyslipidemia was noted 
to be 78%. The prevalence was observed to be much higher in the obese female subjects (81.43%) 
than the obese males (75%). Mean triglycerides levels were significantly higher in the obese men than 
females while,  HDL–C levels were higher in the female subjects (p<0.05). Further, it was seen that low 
concentration of  HDL was the most prevailing deranged lipid parameter (52.67%) followed by elevated 
triglycerides levels (49.33%) and elevated LDL levels (39.33%) in these obese adults. The study thus 
highlights the importance of regular and timely screening for apparently healthy populations. Advocating 
suitable and timely medical and dietary interventions can help in both monitoring and avoiding further 
health-related complications.
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INTRODUCTION
World Health Organization defines 
overweight and obesity as ‘abnormal or excessive 
fat accumulation that may impair health’ (WHO, 
2019).  Obesity is an independent risk factor for 
dyslipidemia, Type2 Diabetes, and Coronary 
artery disease and is rising in prevalence 
throughout the developed and developing 
countries (Jacob et al. 2014). In India obesity is 
emerging out to be a major health threat.
In India, the prevalence of obesity is 
increasing rapidly. In urban areas, the prevalence 
of obesity ranges from 13–50% while in rural 
areas the prevalence rate ranges from 8% to 
38% (Mahajan & Batra 2018). According to the 
National Family Health Survey -NFHS-4 (2015-
2016) data the prevalence of obesity in India 
among adults (15–49 years) is reported to be 
20.6% in women and 18.9% in men (IIPS 2017) 
. In Delhi, the prevalence rate is much higher 
than the national prevalence (33.5% and 26.4% 
among women and men respectively).  According 
to ICMR-INDIAB study, the prevalence of 
obesity and central obesity varied from 11.8% 
to 31.3% and 16.9%–36.3% respectively across 
three states and one union territory in India 
(that is, Jharkhand, Maharashtra, Tamil Nadu & 
Chandigarh respectively; Pradeepa et al. 2015).
The rising prevalence is associated directly 
with obesity-related co-morbidities like high blood 
pressure, metabolic syndrome, dyslipidemia, 
diabetes mellitus (type 2), and cardiovascular 
disease  (Jacob et al. 2014; Dewi 2007). 
Aberrations related to cholesterol lipoproteins 
such as elevated cholesterol,  VLDL, LDL  and 
triglycerides and/or low HDL levels are major risk 
factors related to Coronary Heart Disease (CHD) 
(Gupta et al.  2017). Dyslipidemia, a group of 
biochemical disorders, is frequently encountered 
in obese individuals (NCEP 2002). Dyslipidemia 
is defined as the presence of any of the lipid 
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aberrations existing alone or in the combination 
that is: elevated levels of TC or LDL-C or serum 
TG or a lower level of HDL-C” (Chandra et al. 
2014). 
Abnormalities in lipid metabolism are 
very common in individuals who are obese. 
Approximately 60–70 percent of patients 
with obesity have dyslipidemia (Feingold & 
Grunfeld 2000). Obesity-associated dyslipidemia 
undoubtedly plays a significant role in the 
development of atherosclerosis as well as  CVD in 
obese individuals (Howard et al. 2003). Obesity, 
a modern world pandemic, is closely linked to 
dyslipidemia, which is mainly driven by the 
effects of insulin resistance and proinflammatory 
adipokines. Nevertheless, recent evidence 
indicates that obesity-induced dyslipidemia is 
not a single pathophysiological phenomenon, but 
has unique characteristics depending on many 
varying factors (Vekic et al. 2019). Elevated levels 
of triglycerides and low levels of HDL-C are 
metabolically interrelated. Amongst South Asians, 
this metabolic phenomenon is further associated 
with elevated levels of small LDL particles 
regardless of comparatively normal levels of 
LDL-C (Bilen et al. 2016). This is accompanied 
by a common metabolic derangement known 
as ‘atherogenic dyslipidemia’(Patel et al. 2010; 
Sharobeem et al. 2007; Enas et al. 1996; Misra & 
Khurana 2010).
The aim of the present study was thus to 
assess the prevalence and pattern of dyslipidemia 
in apparently healthy obese adults in the urban 
population of South Delhi.
METHODS
Design, location, and time
The present cross-sectional study was 
conducted in South Delhi, India. Participants 
were recruited from South Delhi by holding 
health camps at different locations after taking 
necessary permissions from the concerned 
authorities which were primarily Resident 
Welfare Association (RWA) of the localities. 
These health camps were organized with the help 
of RWA’s and local health practitioners of the 
concerned areas. Purposive sampling was done 
to recruit apparently healthy obese adults who 
volunteered to be part of the study based on the 
inclusion criteria.  The data were collected from 
November 2016 to September 2017.
Sampling 
The present cross-sectional data is a part 
of another ongoing study that is being conducted 
on 400 subjects. Data from a sub-sample in 
relation to dyslipidemia is being reported here 
for 150 apparently healthy, free-living; obese 
adults comprising of both males and females. The 




p: Prevalence (10%) (Prevalence of dyslipidemia 
in Indian adults = 10%, (Ranganathan et al. 2015; 
Misra et al. 2004). 
The apparently healthy obese adults 
belonging to the age group of 35–50 years who 
were willing to participate in the study were 
recruited. Previous studies indicate that the 
cardiometabolic risk factors are high in middle-
aged adults therefore this age range was selected. 
Further, obese individuals are often at a higher risk 
of developing cardiometabolic disorders and thus 
their dyslipidemia treatment is often indicated. 
So, it is important to assess the cardiometabolic 
risk among these subjects.
Subjects with a history of any chronic 
disease like hypertension, diabetes, etc. or those 
on medications for hypertension, diabetes or 
dyslipidemia; as well as pregnant and lactating 
women were excluded from the study.
Data collection 
Information related to socio-demographic 
characteristics like gender, religion, age, family 
set up and marital status was collected using a 
pre-tested self-administered questionnaire. 
Anthropometric measurements. Weight 
and height were taken following standard 
procedures. Weight was taken using a calibrated 
electronic bathroom scale. To assess the accurate 
weight of the participants, it was ensured that 
the shoes and any heavy clothing were removed. 
They were asked to remove other heavy objects 
on them or any such things in their pockets (like 
mobile phones, wallets, coins, heavy jewellery, 
watches, etc.). Weight was measured first thing in 
the morning before breakfast when subjects were 
in fasting state. For measuring height, commercial 
stadiometer was used. Height was measured using 
standard protocols in centimetres (to the nearest 
0.1 cm). Obesity was defined using Asian criteria 
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to define obesity i.e. BMI of ≥25 kg/m2 among 
both the genders (Misra et al. 2009).
BMI (kg/m2) = weight (in kg)/height (in meters, 
square)
The non-stretchable fibre-glass tape was 
used to measure the waist and hip circumference 
to the nearest 0.1cm. ference to the nearest 0.1cm. 
Hip circumference. Was measured at the 
maximum width of the buttocks and the waist 
measurement was taken at the point which is mid-
way between the inferior margin of the last rib and 
the crest of the ileum in a horizontal plane passing 
the tape snugly but not tightly. All anthropometric 
measurements were taken twice and the mean of 
the two readings was used for analysis. Using 
anthropometric measures, anthropometric ratios 
like ‘waist to hip’ and ‘waist to height’ ratios 
were calculated using standard formulas:
Waist to hip ratio = waist circumference (cm)/
hip circumference (cm)
Waist to height ratio = waist circumference 
(cm)/height (cm)
For both male and female subjects, 0.5 was 
used as reference cutoff for the waist to height 
ratio (Ashwell & Gibson 2016) and WHO-
Asian cutoffs that are, 0.85 and 0.90 were used 
as reference cutoffs for the waist to hip ratio for 
female and male subjects respectively (WHO 
2011).     
Biochemical assessments. Blood samples 
of the study participants were withdrawn after 
overnight fasting 8–10 hours by a trained 
technician and the analysis was carried out 
under standardized procedures in a well-
established ISO 9001: 2001 certified laboratory. 
Lipid parameters were determined using the 
following methods: 1. Cholesterol-CHOD-
PAP method: The concentration of serum 
total cholesterol was determined by modified 
Roeschalu et al. 1974. Principle Cholesterol 
esterase converts cholesterol esters to cholesterol 
and fatty acid. Cholesterol Oxidase (CHOD) 
and Peroxidase (POD) catalyses the conversion 
of cholesterol and hydrogen peroxide to red 
colour quinoneimine dye. The absorbance of 
quinoneimine measured at 505 nm is proportional 
to cholesterol concentration in the specimen; 2. 
Triglyceride-GPO Trinder method: The serum 
triglyceride was determined by the enzymatic 
method, employing lipoprotein lipase, glycerol 
kinase, Glycerol Phosphorase Oxide (GPO) and 
peroxidase (McGowan et al. 1983); 3. HDL- 
Phosphotungstic acid and Mg2 + ions directly 
precipitate low-density lipoprotein & VLDL and 
can then be extracted by centrifugation. High-
Density Lipoprotein (HDL) remain supernatant. 
HDL cholesterol is estimated in the supernatant, 
using cholesterol working reagent, by a series 
of enzymatic reactions which are induced by 
the cholesterol oxidation into Cholestenone by 
cholesterol oxidase, followed by the formation of 
hydrogen peroxide. Further, 4-aminoantipyrine 
and phenol react with hydrogen peroxide to form 
red-coloured quinoneimine in a second reaction 
catalysed by peroxidase (Burstein & Allison 
1970); 4. LDL- LDL cholesterol was estimated 
by the Friedewald calculation from fasting 
measurements i.e,
LDL = TC - (HDL + Triglycerides/5) 
(Friedewald et al.1972)
Dyslipidemia. Dyslipidemia was defined 
as'  a presence of any of the abnormalities, 
occurring alone or in a combination-increased 
concentration of TC or LDL-Cor serum TG or a 
decreased concentration of HDL-C’ using NCEP 
(2002) guidelines: 1. Hypercholesterolemia 
– cholesterol levels (serum) of ≥200 mg/dl; 2. 
Hypertriglyceridemia–triglyceride levels (serum) 
of ≥150 mg/dl; 3. Low HDL cholesterol – HDL 
cholesterol levels of <50 mg/dl for femlaes and 
<40 mg/dl for males; 4. High LDL cholesterol 
– LDL cholesterol levels of≥130 mg/dl calculated 
using the Friedwald’s equation.
Ethical approval. The study protocol was 
approved by the Institutional Ethics Committee, 
Institute of Home Economics, University 
of Delhi (Ethics No: IHE/2016/Ethics/018). 
Written informed consent was taken from all the 
participants in English as well as in Hindi.
Data analysis 
Data were double entered in Microsoft 
Excel 2007. For statistical analysis of the data 
Statistical Package for Social Sciences (SPSS) 
version, 25 was used. A two-tailed ‘p’ value 
was used for calculating statistical significance; 
a value of p<0.05 was taken to be significant. 
Descriptive statistics were calculated for 
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quantifiable variables (means and standard 
deviation). Comparison of means between the 
male and female participants was done using the 
t-independent test. For assessing the significance 
of the categorical variables chi-square value was 
computed.
RESULTS AND DISCUSSION
The socio-demographic characteristics of 
the study participants revealed that out of the 
total study subjects enrolled (n=150), 53% (n=80) 
were males and 47% (n=70) of the subjects were 
females. The mean age of the study participants 
was 41.36±4.75 years (viz. 41.53±4.64 years for 
male subjects and 41.19±4.91 years for female 
subjects). Majority of the participants were 
vegetarians (52.66%) while the rest 47.33 % 
were non-vegetarians. Among vegetarians, the 
proportion of lacto-vegetarians was higher than 
the Ovo-Lacto vegetarians (72.15% and 31.64 
% respectively). The nuclear family set up was 
predominantly seen as 66 % of the subjects 
belonged to nuclear families while only 34% 
had a joint family setup. The data is typical 
of an Indian urban setup. As far as religion is 
considered, the majority of the participants were 
Hindus (69%) followed by others like Muslims 
(13%), Christians (17%) and Sikhs (1%).
Table 1 highlights the anthropometric 
profile of the respondents. The mean BMI of the 
study subjects was reported to be 27.77±2.68 kg/
m2 (28.4±3.28 kg/m2 vs 27.06±1.53 kg/m2 for 
male and female subjects respectively). Since 
the subjects recruited were all obese, this is well 
depicted in their distorted anthropometric profile. 
Means for anthropometric indices like waist to 
height and waist to hip ratio were higher than the 
reference cut off points for both the genders.
The mean values for the lipid parameters 
that is, total cholesterol, triglycerides, and LDL 
for the total study subjects were reported to 
be 173.22±24.73 mg/dl, 164.52±64.79 mg/dl, 
96.91±25.22 mg/dl respectively. Mean HDL for 
male and female subjects was 42.40±4.56 mg/
dl and 44.58 mg/dl respectively. Gender wise 
stratification of the results (Table 2) showed that 
there existed a significant difference in the mean 
triglycerides (p-0.04*) and HDL levels (p-0.000*) 
among obese male and female subjects.
The modified National Cholesterol 
Education Program–Adult Treatment Panel-III 
(NCEP 2002) reference values were applied to 
classify lipid parameters and assess dyslipidemia. 
In the present study, the prevalence of 
dyslipidemia was assessed to be 78%  (Figure 1).
The prevalence was higher in obese female 
subjects in comparison to the obese male subjects 
(that is, 81.43% and 75% respectively). The 
difference, however, was statistically insignificant 
(p-value 0.34). The results are of great concern 
as the subjects were apparently healthy with no 
prior history of any chronic diseases. 
Figure 2 further distributes subjects 
according to the abnormal lipid parameter. 
The prevalence of elevated total cholesterol, 
triglycerides, low high-density lipoprotein 
cholesterol and low-density lipoprotein 
cholesterol was observed to be 12.66%, 49%, 
52.66%, and 39.33% respectively. In females, 
low HDL was the most prevalent deranged 
lipid parameter (81.43%) followed by elevated 
triglycerides (41.43%) and high LDL levels 
(40%). In the case of men, however, high 
Table 1. Anthropometric profile of the subjects
Males (n=80) Females (n=70) p-value
Age (years) 41.53±4.64 41.19±4.91 0.66
Height (cm) 165.5±8.52 155.76±6.21 <0.001*
Weight (kg) 77.83±8.52 65.69±5.57 <0.001*
Waist circumference (cm) 94.04±11.77 91.24±6.41 0.07
Hip circumference (cm) 102.42±8.54 104.46±5.71 0.09
Body mass index(kg/m2) 28.4±3.28 27.06±1.53 0.002*
Waist /hip ratio 0.92±0.07 0.88±0.07 0.000*
Waist /height ratio 0.57±0.07 0.59±0.04 0.08
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triglycerides levels (56.25%) followed by high 
LDL (38.75%) and low HDL levels (27.50%) 
were the most common deranged parameters. It 
was interesting to note here that high cholesterol 
was not common among these obese adults. Only 
12.67% of the total subjects were reported to 
be hypercholesterolemic (14.29% and 11.25% 
of males and females respectively). Figure 3 
further distributes subjects with dyslipidemia 
for the presence of several abnormal blood-lipid 
parameters as per NCEP ATP III guidelines. As 
many as 29.91% of the total obese adults had a 
presence of any one of the lipid parameter that 
was deranged (viz. 36.67% in men and 22.81% 
women).
Almost half of them (49.57%) had the 
presence of any two abnormal lipid parameters, 
while 5.98% of them had abnormalities in all 
the four lipid parameters. A similar pattern was 
observed when data were stratified based on 
gender where the majority of obese men (52.63%) 
and women (46.67%) had the presence of any 
two abnormal lipid parameters. Greater number 
of female participants had the presence of any 
3 abnormal lipid parameters (that is 21.05% in 
females and 8.33% in males).
The present study reports a high prevalence 
of dyslipidemia (78%) among apparently healthy 
urban obese adults. The study results agree with 
many other studies that highlight the substantial 
burden of dyslipidemia in India. 
The overall prevalence of dyslipidemia 
in India ranges from 10% to 73% depending on 
the area of residence (rural vs. urban), socio-
economic strata (high vs. middle low), diet and 
physical activity patterns and age (Ranganathan 
et al. 2015).
 Numerous studies have documented the 
prevalence of various forms of lipid disorders 
among Indians. Not only is the prevalence of 
dyslipidemia high among Indians,  but it has also 
steadily increased in recent decades. Adults who 
are obese also have a greater risk of establishing 
dyslipidemia and associated health problems. 
Recent research has shown that adults with severe 
obesity may have a lower life expectancy of 15–
20 years than individuals who are normal weight. 
In obese adults, a large proportion of morbidity 
and mortality is attributed to sudden cardiac arrest 
and congestive heart failure which is associated 
with obesity (Chitra et al. 2012). Gupta et al. 
(2008) reported a significant association between 
increasing dyslipidemias with increasing obesity 
and truncal obesity
Indian dyslipidemic adults are often 
characterized by having significantly lower high-
density lipoprotein cholesterol and elevated 
triglyceride levels (Dalaal et al. 2016). The same 
characteristics were reported in the present study 
where low HDL levels and high triglycerides 
were the most common abnormal lipid 
parameters. The ICMR–INDIAB study that was 
conducted in four Indian states (i.e., Maharashtra, 
Jharkhand, Tamil Nadu and  Jharkhand ) reported 
that despite the regional differences, low HDL-C 
was the most common lipid abnormality in all 
the four regions studied and 44.9% had isolated 
low HDL cholesterol (Joshi et al. 2014). This 
study thus confirms the findings of several earlier 
Table 2. Lipid profile of the subjects
Lipid parameter (mg/dl) Males (n=80) Females (n=70) p-value
Cholesterol 173.96±25.42 172.38±24.10 0.69
Triglycerides 174.32±71.26 153.32±54.90 0.04*
High-density lipoprotein 42.40±4.5 44.58±5.56 0.00*
Low-density lipoprotein 96.87±24.61 96.96±26.09 0.98
Figure 1. Prevalence of dyslipidemia  in the   
                subjects
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studies that Indians have a high prevalence of 
low HDL cholesterol. This appears to be part 
of the Asian Indian phenotype (Deepa et al. 
2006). Ranganathan et al. (2015) reported a high 
prevalence of dyslipidemia in the obese adults in 
comparison to adult with normal BMI in Salem, 
Tamil Nadu. Among the high BMI group, 59% 
had hypercholesterolemia, 42% had HDL-C of 
<30 mg/dl, 41% had LDL-C of >130 mg/dl, 56% 
had very-low-density lipoprotein (VLDL)-C of 
>40 mg/dl and 55% had TG >150 mg/ dl.
One of the characteristic features of obesity-
related dyslipidemia is elevated fasting and 
postprandial TG combined with the prevalence 
of small dense LDL and lower levels of  HDL-C 
(Klop et al. 2013), Indians and migrant from 
South Asia tend to have higher triglyceride levels 
and lower HDL cholesterol with lower total 
cholesterol levels than in the general population 
in the US and the UK (McKeigue et al. 1989; Enas 
2000). This is in concordance with the present 
study as high cholesterol was the least prevalent 
abnormal lipid parameter among the subjects. 
Data from the western countries illustrates that 
total cholesterol is the most common deranged 
lipid parameter and unlike South Asians, they 
are reported to have better HDL levels. In recent 
research among Asian Indian immigrants in the 
United States, it was noted that the prevalence 
of hypercholesterolemia was 43.5%, while that 
of hypertriglyceridemia of 42.3%, low HDL and 
high LDH were 42.3%, 26.4% 41.4% respectively 
(Misra et al. 2010). Jordanian adults reported 
similar prevalence rates, with a prevalence 
of 48.8% hypercholesterolemia, 43.6% 
hypertriglyceridemia, 40.1% low HDL-C and 
40.7% high LDL-C (Khader et al. 2010). Among 
Turkish adults also the prevalence rates were much 
similar that is, hypercholesterolemia (37.5%), 
high triglycerides (30.4%), low HDL-C (21.1.%) 
and high LDL-C (44.5%) (Erem et al. 2008).
CONCLUSION
The study result highlights the high 
prevalence of dyslipidemia (78%) among adult 
obese subjects who were apparently healthy. 
It was observed that low HDL levels and high 
triglycerides were the most common abnormal 
lipid parameters. The results are of great 
concern as the subjects had no prior history 
of any chronic diseases. The high prevalence 
among asymptomatic urban adults emphasizes 
the importance of regular and timely screening 
for apparently healthy populations and further 
advocating adequate medical and dietary 
intervention that can help in controlling and 
preventing health-related complications.
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